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ABSTRACT 
Objective: The aim of this work is to investigate formulation and process parameters that could impact freeze drying of loperamide-loaded Solid 
Lipid Nanoparticles (Loperamide loaded SLN). 
Methods: Loperamide loaded SLN was prepared by high shear homogenization method and freeze dried in vials without and with different types 
and concentrations of cryoprotectants (lactose, glucose, mannitol and povidon) using pilot freeze dryer. 
Results: The best result has been obtained by using 5 % of monosaccharide glucose solution, although Nanoparticles size has been increased 6 
folds. However, the total concentration of loperamide hydrochloride (Loperamide HCl) remained unchanged after freeze drying. It has been found 
that the type and ratio of surfactants adsorbed at the surface of SLN have impact on the success of the drying process. 
Conclusion: Results revealed that polymeric nanoparticles could withstand freeze drying stress more than SLN because polymers have higher 
mechanical resistance in comparison with waxes and lipids. 
Keywords: Solid lipid Nanoparticles, Lyophilization, Stability, Brain targeting. 
 
INTRODUCTION 
In recent years, it has become evident that the development of new 
active ingredients is not sufficient to ensure progress in drug 
therapy. Promising experimental data obtained in vitro are very 
often followed by unsuccessful results in vivo. Main reasons for this 
failure include:  
- Insufficient drug concentration due to poor absorption, rapid 
metabolism and elimination.  
- Drug distribution to other tissues combined with high drug 
toxicity. 
- Poor drug solubility, which excludes intravenous injection of 
aqueous drug solution. 
- High fluctuation of plasma levels due to unpredictable 
bioavailability after per oral administration [1]. 
During last decades, new drug delivery systems have been 
developed to overcome the previous problems. These delivery 
systems offer a possibility to provide targeted delivery of drugs, 
improved bioavailability, or controlled drug release in target tissue 
In the middle of the 1990s, new type of nanoparticles made from solid 
lipids (SLN or lipospheres) appeared. The SLNs combine the 
advantages of other innovative carry systems such as; physical 
stability, protection of incorporated labile drugs from degradation, 
controlled release, excellent tolerability, avoidance of organic solvents 
and the possibility of large scale production and sterilization [2]. 
Solid lipid nanoparticles can be defined as submicron colloidal solid 
systems made from lipids such as waxes. The main disadvantages of 
SLN are the lack of physical (agglomeration and fusion of particles) 
and chemical (Oxidation of lipids) stability during long-term storage. 
To improve the physical and chemical stability of SLN, water should be 
removed from the colloidal suspension. Freeze drying is the most 
common technique applied for making SLN system to allow extended 
periods of shelf-lives. Lyophilization or freeze drying can transform 
colloidal suspensions into stable solid cakes for long term storage. 
Freeze drying is an industrial process which involves water removal 
from frozen samples by sublimation under vacuum. However, it is a 
complex process that generates stress sources itself, which can 
destabilize the nanoparticles formulation in the process such as 
freezing and drying stresses. Cryoprotectants have been used to 
decrease SLN aggregations due to the stress during the process of 
freeze-drying. For this reasons, both formula and process should be 
carefully studied to select the suitable excipients and optimal freeze 
drying conditions [3].  
Successful nanoparticles lyophilizate should have:  
- Elegant aspect. 
- Short reconstitution time in water. 
- Physical and chemical stability (ex: particle size, encapsulation 
efficiency) 
- Low residual water [4]. 
Loperamide hydrochloride is a common-used anti diarrhea drug, an 
opioid agonist that is unable to cross the blood-brain barrier (BBB). 
In this work, Loperamide was loaded on nanoparticles to improve its 
crossing to BBB and to have a strong central analgesic effect [5]. 
So far, there have been few studies into achieving freeze-dried SLNs 
using different cryoprotectants. The aim of this research was to 
study the freeze drying of solid lipid nanoparticles loaded with 
loperamide and to find the suitable excipients and conditions for 
successful lyophilization process. To the best of our knowledge, this 
is the first study of freeze drying of loperamide loaded SLN. 
MATERIALS AND METHODS 
Materials 
Loperamide hydrochloride was supplied by sigma-Aldrich (Italy). 
Beeswax, carnauba wax, and egg lecithin was all obtained from Carl 
Roth (Germany). The surfactant Tween 80 was purchased from 
Sigma-Aldrich (France). Triton x was supplied by Rasayan 
Laboratories and finally, HPLC grade acetonitrile was provided from 
Scharlau (spain). 
Preparation of solid lipid nanoparticles 
Loperamide loaded SLN was prepared by High shear homogenization 
method. Briefly, a mixture of beeswax (0.48 g), carnauba wax (0.12 g), 
egg lecithin (0.12 g) and Loperamide hydrochloride (50 mg) was 
melted in a water bath at 65ºC. Then 0.18 mg of tween 80 was mixed 
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with 20 mL of de ionized water at 80 C ͦ  under magnetic stirring (1000 
rpm) for the few minutes and added to the molten lipid-drug mixture. 
The resulting emulsion was homogenized at 24000 rpm during 5 min 
using a rotor-stator (ultra-Turrax, IKA T18 B, Germany), and then 
dispersed in cooled water under stirring. 
Particle size and zeta potential analysis 
The mean size of nanoparticles and poly dispersity index (PdI) was 
determined by photon correlation spectroscopy (PCS), using a Malvern 
Zetasizer Nanoseries (Zetasizer Nano ZS, Malvern instruments, England). 
Zeta (ζ) potential measurements were made with the same instrument 
by Smoluchowski’s equation from electrophoretic mobility of 
nanoparticles. All measurements were performed at 25 °C. 
Determination of encapsulation efficiency 
Loperamide association efficiency (AE) was indirectly determined to 
quantify the amount of active ingredient effectively entrapped into 
the produced SLN. Total loperamide concentration (TL) was 
determined after dissolution of 1 mL of the nano suspension in 3 mL 
of triton x (5%) then sonicated for 25 min. after that strong magnetic 
stirring was applied for about 25 min. The final volume was adjusted 
to 10 mL with the mobile phase used for high performance liquid 
chromatography (HPLC) analysis method. 
Free loperamide concentration (FL) was determined after 
separation of loaded-NPs from the aqueous medium by 
ultracentrifugation (CP 80 WX Himac preparative ultracentrifuge, 
Hitachi, Japan). 1 mL of samples was centrifuged at 40000 rpm for 
30 min at 25 °C The free loperamide concentration was then 
determined in the supernatant by a HPLC-UV method which was 
applied exactly as reported in USP 34 NF29 2011 pharmacopeia. 
HPLC separation was performed with Agilent Liquid Chromatographer 
(1260 Infinity, Agilent, Germany). Quantitative measurement of 
loperamide content was done at 214 nm. Loperamide was separated on 
a silica gel column (EC 150/4.6 Nucleodur 100-3 C8, Macherey-Nagel, 
Germany) with a mobile phase of buffer solution: acetonitrile (63:37) 
(v/v) at 1.5 ml/min. The samples were run in triplicate and all 
measurements were performed at 25 °C. The encapsulation efficiency 
was calculated as follows:  
Encapsulation efficiency (%) = (TL–FL/TL) x 100 
Thermal analysis 
To measure the glass transition temperature of maximally cryo 
concentrated suspension (Tg’), a thermal analysis was performed by 
a differential scanning calorimeter DSC TA 125 (TA instrument, 
USA). A certain amount of samples heated from (-100 to 30 °C), and 
a heating rate of 10 °C/min was applied throughout the analysis. The 
instrument was calibrated with indium for melting point and heat of 
fusion. 
Freeze–Thaw study of nanoparticles 
In order to evaluate the resistance of nanoparticles during freezing, 
this is the first step of lyophilization. 0.5 mL of nanoparticles 
suspension was filled into a 7 mL freeze drying vials after mixing 
with 0.5 mL of cryoprotectant solution. Samples freezing was 
performed on a shelf of pilot-scale freeze dryer (EPSILON 2-6D 
Martin Christ, Germany). Freezing was hold for two hours at–45 °C 
using cooling rate of 1 °C/min. The frozen preparations were kept at 
room temperature for thawing. The particle size was determined 
before freezing and after thawing, and the final to initial size ratio 
(Sf/Si) was also calculated. 
Freeze drying of nanoparticles 
SLN were freeze-dried using lactose, glucose, mannitol and povidon 
as cryoprotectants. Thus, 0.5 mL of cryoprotectant solutions was 
added to 0.5 mL of nanoparticles suspension and homogenized. 
Samples were poured into 7 mL freeze drying vials. 
The lyophilization of nanoparticles was realized on a pilot freeze 
dryer (EPSILON 2-6D Martin Christ, Germany). The applied 
conditions during our study were as following: freezing for 2 h at–45 
°C with a temperature ramp of 1 °C/min, sublimation at-30 ͦ C and 10 
pascal for 12 h and finally, secondary drying was carried out at 20 °C 
and 5 pascal for 6 h.  
RESULTS AND DISCUSSION 
In this work, solid lipid nanoparticles were prepared by High shear 
homogenization method. The optimized nanoparticles formulation 
was produced with a mean diameter in the colloidal range (about 80 
nm) less than 200 nm, which is suitable for brain targeting.  
From table 1, it can be observed that loperamide loaded SLN size 
and poly dispersity index do not change significantly in 
Comparison with unloaded nanoparticles. However, the value of 
zeta potential values was highly changed from about-32 mV to 
about+17 mV. This result could be explained by the adsorption of 
Loperamide on the particles surface, which indicates the high 
compatibility between the drug substance and the lipids forming 
the lipospheres. 
 
Table 1: Characterization of loperamide loaded and unloaded solid lipid nanoparticles 
Nanoparticles Size (nm)±SD PDI±SD Zeta potential(mV)±SD Encapsulation efficiency (%)±SD 
Without loperamide 90±7 0.43±0.07 -32±0.8 - 
loperamide loaded 79.8±0.2 0.43±0.01 +17.7±0.8 54±0.6 
N = 3, SD: standard deviation between the three assays 
 
Loperamide hydrochloride is a salt of strong acid and the acid group 
ionizes in water and produces protons and chloride negative ions which 
results in the protonation of the nitrogen atom in the Pepperdine cycle. 
This positive proton is responsible of the appearance of the positive 
charge on the nanoparticles surface. Consequently, zeta potential values 
have changed to the positive value (fig. 1). 
 
 
Fig. 1: Chemical structure of loperamide hydrochloride 
Freeze drying of nanoparticles needs experience and knowledge of 
both formulation and freeze drying conditions in order to keep 
nanoaprticles properties and protect them from degradation. 
Freezing is considered the most aggressive and critical step during 
lyophilization. This step can cause aggregation or destruction of 
nanoparticles. Normally, freeze drying study starts with freeze–thaw 
experiments to evaluate the effect of freezing conditions and 
protecting excipients on nanoparticles properties. In this study, four 
different types of protecting excipients have been investigated 
which are: Mannitol (polyol), lactose (disaccharide), glucose 
(monosaccharide) and povidone (polymer) [6]. Freezing of SLN was 
conducted in the presence of 5% solution of cryoprotectant at–45 °C 
and cooling rate 1 ͦ C/min. Table 2 shows the results of this study. 
The used cryoprotectant can be considered more effective in the 
protection of nanoparticles during freezing when the properties of 
particles before and after freezing are unchanged (Particles size, 
poly dispersity index, zeta potential). Furthermore, the calculation of 
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Sf/Si ratio can help in the evaluation of excipients as a value close to 1 indicates good preservation of nanoparticles. 
 
Table 2: Effect of Loperamide loaded SLN freezing by using of 5% of cryoprotectant solution 
 Before freezing (average±SD) After freezing  (average±SD) 
Cryoprotectant Mean size (nm) PdI Z. P(mV) Mean size 
(nm) 
PdI Z. P.(mV) Sf/Si 
Without 
excepients 
79.8±0.2 0.43±0.01 +17.7±0.8 visible particles formed - 
Manitol Nanoparticles properties have not changed after mixing with 
cryoprotectant solution  
1490.5±298 0.64±0.06 +12.05±0.45 18.6 
Lactose 3097±442 o.18±0.11 +13.5±0.8 38.8 
Glucose 1514.5±145 0.99±0.01 +12.95±0.15 18.9 
Povidone 1693±156 0.68±0.03 +8.2±0.18 21.2 
N = 3, SD: standard deviation between the three assays 
 
After freezing, zeta potential value was slightly reduced which 
indicates a good association of loperamide with the surface of 
nanoparticles and shows that freezing dissociates only small part of 
loaded loperamide (table 2). 
However, particle size and poly dispersity index were highly 
increased when using all excipients which indicates the aggregation 
of nanoparticles under the stress of ice crystals. For this reason, the 
concentration of cryo protectants was increased to 10 %.  
Table 3 shows that the size and poly dispersity index of SLN clearly 
increased after freezing in the presence of 10 % of cryoprotectant. 
By comparing these results with these in table 2, it can be noticed 
that the results were better in the presence of 5 % of cryoprotectant 
solution. Furthermore, zeta potential reduced after freezing more 
significantly than its reduction when using 5 % of excipient solution. 
This result confirms a dissociation of larger part of loperamide from 
the particle's surface after freezing. In general, glucose and mannitol 
gave the best results. 
 
Table 3: Effect of Loperamide loaded SLN freezing by using of 10% of cryoprotectant solution 
 Before freezing (average±SD) After freezing  (average±SD) 
Cryoprotectant Mean size (nm) PdI Z. P(mV) Mean size (nm) PdI Z. P.(mV) Sf/Si 
Without 
excepients 
93.38±5 0.514±0.1 +9.83±0.1 visible particles formed - 
Manitol  
Nanoparticles properties have not changed after mixing with 
cryoprotectant solution  
4571±203 0.638±0.03 +0.89±0.03 48.9 
Lactose 2439.5±204 0.673±0.05 +3.5±0.1 26.1 
Glucose 7524.5±135 0.921±0.27 +9.98±0.45 80.5 
Povidone 5999±722 0.638±0.22 -6.19±0.3 64.2 
N = 3, SD: standard deviation between the three assays 
 
Freeze drying may generate many stresses that could destabilize 
colloidal suspension of nanoparticles, especially, the stress of 
freezing and dehydration. It is well known that during freezing of a 
sample there is a phase separation into ice and cryo-concentrated 
solution. In the case of suspension of nanoparticles this cryo-
concentrated phase is composed of nanoparticles and the other 
components of the formulation [3]. 
This high concentration of particulate system may induce the 
aggregation and in some cases irreversible fusion of 
nanoparticles. Furthermore, the crystallization of ice may 
exercise a mechanical stress on nanoparticles leading to their 
destabilization. For these reasons, special excipients must be 
added into nanoparticles suspension before freezing to protect 
these fragile systems. 
Sugars are the most cryoprotectants used in freeze drying of 
nanoparticles especially, trehalose, sucrose and glucose. These 
sugars are known to vitrify at a specific temperature denoted Tg’ 
(glass transition temperature of maximally cryo-concentrated 
solutions) [7]. The immobilization of nanoparticles within a glassy 
matrix of cryoprotectant can prevent their aggregation and protect 
them against the mechanical stress of ice crystals. 
Generally, freezing must be carried out below Tg’ of a frozen 
amorphous sample or below Teu (crystallization temperature of 
soluble component as a mixture with ice) if it is in the crystalline 
state to ensure the total solidification of the sample [7]. 
The level of stabilization afforded by sugars generally depends on 
their concentrations. It has been proved that trehalose is more 
effective for stabilizing both comprotol solid lipid nanoparticles and 
glycerol trilaurate SLN during freeze drying at concentration 15 %, 
whereas 2 % of trehalose was not sufficient to protect the 
nanoparticles [8] 
On the other hand, in some cases, increasing the cryoprotectant 
concentration to a certain level may eventually reach a limit of 
stabilization or even destabilize nanoparticles. For example, particle 
aggregation increased with higher glucose concentration during 
freeze drying of cationically modified silica nanoparticles [9].  
This finding may explain the better result obtained in this work with 
the concentration 5 % in comparison with the concentration 10 % of 
cryoprotectant during freezing.  
In our previous work, using monosaccharides at concentration 5 
% was sufficient to protect polymeric (poly (D, L-lactide-co-
glycolide) and poly caprolactone) nanoparticles during freezing. 
This result indicates that polymeric nanoparticles are more 
resistant to freezing stresses than solid lipid nanoparticles as 
polymers have higher mechanical resistance and are more solid 
than waxes and lipids [6]. 
SLN were freeze dried according to the conditions presented in table 
4 by using 5 % of lyoprotectant. 
It could be observed that during freezing, the sample temperature 
was slightly higher than the shelf temperature because of the low 
thermal conductivity of vial glass, whereas during primary drying 
the sample temperature was lower than the shelf temperature 
because of the cooling resulted from ice sublimation. 
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Table 4: The conditions of nanoparticles freeze drying 












Freezing step -45 -42 1 - 2 - 
Primary drying -30 -32 - -80 12 10 
Secondary 
drying 
+20 +18 - -80 6 5 
 
Fig. 2 presents the resulted lyophilizates of solid lipid nanoparticles. 
Collapse of lyophilizate could be clearly observed when using 
glucose as lyoprotectant, whereas partial collapse was obtained by 
using lactose. Samples protected with mannitol and PVP have a good 
aspect and occupy a volume equals to the original volume of 
solution, which affirm the absence of collapse. 
 
 
Fig. 2: Image shows formulated lyophilizates appearance using 
(from right to left): glucose, lactose and mannitol 
 
Collapse of lyophilizate has negative effects on the freeze dried samples: 
collapsed samples have long reconstitution time and high percentage of 
residual moisture, in addition to the unacceptable aspect [10].  
It can be seen from table 4 that glucose and lactose lyophilizates 
have relatively long reconstitution time comparing with mannitol 
lyophilizate which has shorter reconstitution time. 
 
Table 4: Reconstitution time of nanoparticles lyophilizate 
Nanoparticles lyophilizate Reconstitution time (sec)±SD 
SLNs with lactose 90±7 
SLNs with glucose 144±15 
SLNs with mannitol 66±4 
N = 3, SD: standard deviation between the three assays 
The collapse of glucose samples could be explained by the heating of 
the sample during primary drying into a temperature, that is higher 
than the collapse temperature of glucose lyophilizates, which is 
about–42 °C (table 7), while the sample temperature was about-32 
C. Lactose sample temperature was below the collapse temperature 
of lactose; however, the approach of sample temperature from the 
collapse temperature may enhance the undesired partial collapse. 
The preservation of mannitol and PVP lyophilizates was due to the 
crystallization of mannitol and the relative high collapse 
temperature of PVP (about-21 C). 
 
Table 5: Collapse temperature of some excipients used for 
nanoparticles protection during of freeze drying 
Excipient Collapse temperature (glass transition 
temperature) 
Manitol  Crystallized 
Lactose -30.5 
Glucose  -42 
Povidone -21 
 
Freeze drying results indicate a clear increase in the nanoparticles 
size after drying which affirms particles aggregation. These results 
comply with the freezing results because glucose gave the best 
results (Sf/Si ratio was 6.6). In the case of using lactose as a 
lyoprotectant the ratio Sf/Si was about 27 (high particles 
aggregation). In addition, zeta potential slightly reduced in the case 
of glucose and mannitol and this reduction was more evident in the 
case of lactose. 
These results indicate the efficacy of monosaccharide lyoprotectants 
for the preservation of polymeric and lipid nanoparticles during 
freeze drying as glucose presented excellent results in the case of 
freeze drying of polymeric nanoparticles prepared from 
polycaprolactone and poly lactide co glycolide [6]. 
 
Table 6: Study of loperamide loaded SLNs lyophilization with different excipients 
 Before lyophilization After lyophilization  
Cryoprotectant Mean size (nm) PdI Z. P(mV) Mean size (nm) PdI Z. P.(mV) Sf/Si 
Without excepients 110.5 0.485 +14.1 visible particles formed - 
Manitol Nanoparticles properties have not changed after mixing with 
cryoprotectant solution  
1653±120 0.639±0.18 +5.57±0.37 14.9 
Lactose 3006±108 0.906±0.16 -1.67±0.76 27.2 
Glucose 739.6±60 0.774±0.06 +6.41±0.29 6.6 
N = 3, SD: standard deviation between the three assays 
 
Table 7: Total concentration of Loperamide hydrochloride loaded SLNs suspension before and after lyophilization 
 Total concentration of Loperamide hydrochloride 
before lyophilization (µl/ml)±SD 
Total concentration of Loperamide hydrochloride 












N = 3, SD: standard deviation between the three assays 
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It can be observed that the polymeric nano particles freeze drying results 
are better than these of solid lipid nanoparticles. Perhaps this result may 
be attributed to the more solid structure of polymeric nanoparticles. 
Furthermore, many researches [11] confirmed that the composition 
of surfactants on the solid lipid nanoparticles surface has the crucial 
effect on the success of the lyophilization process. Best results have 
been obtained using weight percent 54:46 of eggs lecithin to Tween 
whereas the percent 40:60 was used in our work.  
The same research affirmed that the SLN size clearly increased after 
freeze drying when using more than 46 % of Tween 80 and this 
result complies with our results. 
About 54% encapsulation efficiency was achieved with loperamide 
hydrochloride loaded SLN, which indicates a good affinity of the 
active ingredient with waxes and lipid forming the particles. 
Table 7 shows the results of loperamide HCl assay before and after 
freeze drying. A slight reducing in the total concentration of the active 
ingredient after freeze drying has been obtained (about 15 %) in the 
case of using lactose, whereas the results were perfect with the other 
excipients without any reduction of active concentration. These results 
comply with the zeta potential measurement results which indicate the 
desorption of  lopera mide from the nanoparticles surface stabilized by 
lactose after freezing. This desorption may be the cause of its partial 
degradation. Also, this result complies with the result of polymeric 
nanoparticles freeze drying prepared from poly lactide co glycolide [6]. 
According to Abdel wahed the total concentration of active ingredient 
was reduced by 15 % when using lactose as lyoprotectant. 
From these results, it can be concluded that the disaccharides are 
less effective as lyoprotecatnt in comparison with monosaccharides 
or polyols for both polymeric and lipid nanoaprticles. 
CONCLUSION 
The type and concentration of protective excipient has important 
role in the success of freeze drying process and in the conservation 
of solid lipid nanoparticles. Best results were obtained by using 5 % 
of glucose. Using glucose at higher concentration resulted in the 
degradation and instability of particles. However, the freeze-drying 
conditions should be precisely controlled to prevent the collapse of 
lyophilizate as glucose has low collapse temperature (about-40 C). 
Furthermore, freeze-drying of solid lipid nanoparticles was less 
successful in comparison with polymeric nanoparticles because of 
their lower mechanical resistance. Freeze drying of SLN led to an 
increase of particle size about six folds when glucose was used as 
lyoprotectant. In addition, the adsorbed stabilizers on the particles 
surface play an important role in the success of freeze-drying that 
they must be added at certain percent. Finally, the lyoprotecatnt 
may keep the active ingredient attached to the surface of particles 
and protect it from degradation. Mono saccharides afforded better 
results than disaccharides. 
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